The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine the effect of multiple doses of Epanova® (omega fatty
acids) on the pharmacokinetics (PK) of multiple 40 mg doses of simvastatin.